Peritumoral lymphatic vessel density as a prognostic parameter in endometrial carcinoma: An immunohistochemical study

Indian Journal of Pathology and Microbiology

Volumn 53, Issue 3, 2010, Pages 471-475

  Maghraby, Hala K ^a   Elsarha, Ashgan I ^a   Saad, Reda S ^b  

^a MRI Alex University   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

D2 40 immunostaining; endometrial carcinoma; lymphatic vessel density

Indexed keywords

MONOCLONAL ANTIBODY D2-40; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; LYMPHANGIOMA; MAJOR CLINICAL STUDY; PELVIS LYMPH NODE; PROGNOSIS; RISK FACTOR; BIOMETRY; ENDOMETRIUM TUMOR; LYMPH VESSEL; METASTASIS; METHODOLOGY; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BIOMETRY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC VESSELS; MIDDLE AGED; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 77955900024     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.68278     Document Type: Article

References (42)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82:4-6.
2. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86:353-364
3. Ellis LM, Fidler IJ. Angiogenesis and metastasis. Eur J Cancer 1996;32A:2451-2460
4. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-Correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
5. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during transition from hyperplasia to neoplasia. Nature 1989;339: 58-61.
6. Weidner N. Intratumor MV density as a prognostic factor in cancer. Am J Pathol 1995;147:9-19.
7. Van Trappen PO, Pepper MS. Lymphangiogenesis in human gynaecological cancers. Angiogenesis 2005;8:137-145
8. Stacker SA, Baldwin ME, Achen MG. The role of tumor lymphangiogenesis in metastatic spread. FASEB J 2002;16: 922-934
9. Maula SM, Luukkaa M, Grenman R, Jackson D, Jalkanen S, Ristamäki R. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 2003;63:1920-1926
10. Beasley NJ, Prevo R, Banerji S, Leek RD, Moore J, van Trappen P, Cox G, et al. Intratumoral lymphangiogenesis and lymph node metastases in head and neck cancer. Cancer Res 2002;62:1315-1320
11. Saad RS, Kordunsky L, Liu YL, Denning KL, Kandil HA, Silverman JF. Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod Pathol 2006;19:1317-1323
12. Pepper MS. Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res 2001;7:462-468
13. Parums DV, Cordell JL, Micklem K, Heryet AR, Gatter KC, Mason DY. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 1990;43:752-757
14. Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos C, Gatter KC, Harris AL, et al. LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer. J Clin Pathol 2005;58:202-206
15. Marks A, Sutherland DR, Bailey D, Iglesias J, Law J, Lei M, et al. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed in testicular germ cell tumors. Br J Cancer 1999;80:569-578
16. Kahn HJ, Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 2002;82:1255-1257
17. Kahn HJ, Bailey D, Marks A. Monoclonal antibody, D2-40: A new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol 2002;15:434-440
18. Greene FL, Page DL, Fleming ID, Balch ChM, Rhit AF, Haller DG et al. Corpus Uteri. 6th ed. American Joint Committee on Cancer: AJCC Cancer Staging manual. New York: Springer; 2002. p. 231-234
19. Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, et al. Quantification of angiogenesis in solid human tumors: An international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996;32A:2474-2484
20. Wrong SY, Hynes RO. Tumor-lymphatic interactions in an activated stromal microenvironment. J Cell Biochem 2007;101:840-850
21. Carmeliet P, Jain RK. Angiogenesis in cancer and other disease. Nature 2000;407:249-257
22. Saad RS, Jasnosz KM, Tung MY, Silverman JF. Endoglin (CD105) expression in endometrial carcinoma. Int J Gynecol Pathol 2003;22: 248-253
23. Kawaguich T. Fundamental aspect of cancer metastasis. Tokyo, Japan: Kanehara A and Co., Ltd; 2002.
24. Padera TP, Kadambi A, di Thomaso E, Carreira CM, Brown EB, Boucher Y, et al. Lymphatic metastasis in the absence of functional intratumoral lymphatics. Science 2002;296:1883-1886
25. Van Trappen PO, Pepper MS. Lymphatic dissemination of tumor cells and the formation of micrometastases. Lancet Oncol 2002;3:44-52.
26. Kuroyama S, Kobayashi N, Ohbu M, Ohtani Y, Okayasu I, Kakita A. Enzyme histochemical analysis of lymphatic vessels in colon carcinoma: Occurrence of lymphangiogenesis within the tumor. Hepatogastroenterology 2005;52:1057-1061
27. Dadras SS, Paul T, Bertoncini J, Brown LF, Muzikansky A, Jackson DG, et al. A novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2003;162:1951-1960
28. Kurahara H, Takao S, Maemura K, Shinchi H, Natsugoe S, Aikou T. Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: Its relationship to lymph node metastasis. Clin Cancer Res 2004;10:8413-8420
29. Franchi A, Gallo O, Massi D, Baroni G, Santucci M. Tumor lymphangiogenesis in head and neck squamous cell carcinoma: A morphometeric study with clinical correlation. Cancer 2004;101:973-978
30. Munoz-Guerra MF, Marazuela EG, Martin-Villar E, Quintanilla M, Gamallo C. Prognostic significance of intratumoral lymphangiogenesis in squamous cell carcinoma of the oral cavity. Cancer 2004;100:553-560
31. Choi WW, Lewis MM, Lawson D, Yin-Goen Q, Birdsong GG, Cotsonis GA, et al. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: Correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol 2005;18:143-152
32. Schoppmann SF, Birner P, Studer P, Breiteneder-Geleff S. Lymphatic microvessel density and lymphovascular invasion assessed by antipodoplanin immunostaining in human breast cancer. Anticancer Res 2001;21:2351-2355
33. El-Gohary YM, Metwally G, Saad RS, Robinson MJ, Mesko T, Poppiti RJ. Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas. Am J Clin Pathol 2008;129:578-586
34. Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, et al. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer 2003;88:237-244
35. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Kowalski H, et al. Lymphatic microvessel density in epithelial ovarian cancer: Its impact on prognosis. Anticancer Res 2000;20:2981-2985
36. Birner P, Schindl M, Obermair A, Breitenecker G, Kowalski H, Oberhuber G. Lymphatic microvessel density as a novel prognostic factor in earlystage invasive cervical cancer. Int J Cancer 2001;95:29-33.
37. Hirai M, Nakagawara A, Oosaki T, Hayashi Y, Hirono M, Yoshihara T. Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma. Gynecol Oncol 2001;80:181-188
38. Renyi-Vamos F, Tovari J, Fillinger J, Timar J, Paku S, Kenessey I, et al. Lymphangiogenesis correlates with lymph node metastasis, prognosis and angiogenic phenotype in human non-small cell lung cancer. Clin Cancer Res 2005;11:7344-7353
39. Vleugel MM, Bos R, van der Groep P, Greijer AE, Shvarts A, Stel HV, et al. Lack of lymphangiogenesis during breast carcinogenesis. J Clin Pathol 2004;57:746-751
40. Williams CS, Leek RD, Robson AM, Banerji S, Prevo R, Harris AL, et al. Absence of lymphangiogenesis and intratumoral lymph vessels in human metastatic breast cancer. J Pathol 2003;200:195-206.
41. Mannelqvist M, Stefansson I, Salvesen HB, Akslen LA. Importance of tumor cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma. Histopathology 2009;54:174-183
42. Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, et al. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 2004;240:306-312